While the presence of FN1 in the ECM has been shown to promote tumor progression and formation of metastasis by activating pro-proliferative signals in certain cancers, it is paradoxically associated with a better prognosis (Lin et al., 2019; Farooq et al., 2023). The gene discussed is FN1; the disease is neoplasm.